Medpace is a scientifically-driven, global, full-service clinical contract research organization (CRO) providing Phase I-IV clinical development services to the biotechnology, pharmaceutical and medical device industries. Medpace’s mission is to accelerate the global development of safe and effective medical therapeutics through its physician-led, high-science, and disciplined operating approach that leverages local regulatory and deep therapeutic expertise across all major areas including oncology, cardiology, metabolic disease, endocrinology, central nervous system and anti-viral and anti-infective. Headquartered in Cincinnati, Ohio, Medpace employs approximately 2,500 people across 35 countries.
|Change (%)||+0.21 (0.58%)|
Date as of
11/22/17 4:00 p.m. ET
Data provided by Nasdaq. Minimum 15 minutes delayed.
October 30, 2017Medpace Holdings, Inc. Reports Third Quarter 2017 Results
There are currently no events scheduled.
Primary IR Contact
|Medpace Holdings, Inc.|
5375 Medpace Way
Cincinnati, OH 45227